Article Figures & Data
Figures
- Figure 1.
Design of the study. FFPE: Formalin-fixed paraffin embedded; RT-qPCR: reverse transcription real time quantitative polymerase chain reaction.
- Figure 2.
MiR-376b-3p expression levels in tumors of patients with primary resistance (PFS=2-5 months, N=30), intermediate response (PFS 5-12 months, N=42) and long-term response to sunitinib therapy (PFS >12 months, N=42). (Kruskall–Wallis test; p=0.0003). Comparison only between patients with primary resistance and long-term response (Mann–Whitney test; ***p=0.0001).
- Figure 3.
Receiver operating characteristic analysis of the miR-376b-3p as a discriminator between patients with primary resistance and long-term response to sunitinib treatment (p=0.0002).
- Figure 4.
Survival curves of patients stratified accordingly to miR-376b-3p expression level (cut-off value=0.0244; p<0.0001).
